SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000259
Filing Date
2021-08-06
Accepted
2021-08-06 13:56:48
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nptx063021form10q.htm   iXBRL 10-Q 1114902
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12234
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11593
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5120
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4998
11 GRAPHIC image_001.jpg GRAPHIC 37415
12 GRAPHIC image_002.jpg GRAPHIC 32392
13 GRAPHIC image_003.jpg GRAPHIC 18317
  Complete submission text file 0001607062-21-000259.txt   5552478

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nptx-20210630.xsd EX-101.SCH 44354
7 XBRL CALCULATION FILE nptx-20210630_cal.xml EX-101.CAL 52656
8 XBRL DEFINITION FILE nptx-20210630_def.xml EX-101.DEF 199345
9 XBRL LABEL FILE nptx-20210630_lab.xml EX-101.LAB 310754
10 XBRL PRESENTATION FILE nptx-20210630_pre.xml EX-101.PRE 289376
14 EXTRACTED XBRL INSTANCE DOCUMENT nptx063021form10q_htm.xml XML 744610
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 858-883-2642
NEUROPATHIX, INC. (Filer) CIK: 0001615999 (see all company filings)

IRS No.: 462645343 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55657 | Film No.: 211152285
SIC: 2834 Pharmaceutical Preparations